← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Seattle Institute For Biomedical And Clinical Research
$26,580,491
Total funding
24
Grants
Funding over time
peak $5.3M · FY2008–24$10M$7.5M$5M$2.5M$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
DOD$26,580,491 · 24
By mechanism
—$26,580,491 · 24
Investigators at Seattle Institute For Biomedical And Clinical Research
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Not enough data
Largest grants
PRAZOSIN FOR PROPHYLAXIS OF CHRONIC POST-TRAUMATIC HEADACHES IN OEF/OIF/OND SERVICE MEMBERS AND VETERANS WITH MILD TBI$3,942,869
· FY2015 · Department of the Army
PROSTHETIC KNEE-ANKLE-FOOT SYSTEM WITH BIOMECHATRONIC SENSING, CONTROL, AND POWER GENERATION$2,743,240
· FY2009 · Department of Defense
ON-TRACC: A NOVEL SELF-MANAGEMENT INTERVENTION TO IMPROVE LONG-TERM OUTCOMES IN VETERANS WITH A HISTORY OF MILD TRAUMATIC BRAIN INJURY$2,492,619
· FY2022 · Defense Health Agency
A PROSTHETIC FOOT EMULATOR TO OPTIMIZE PRESCRIPTION OF PROSTHETIC FEET IN VETERANS AND SERVICE MEMBERS WITH LEG AMPUTATIONS$2,450,265
· FY2016 · Department of the Army
A PROSTHETIC FOOT TEST-DRIVE STRATEGY FOR IMPROVING STABILITY AND FALLS-RELATED OUTCOMES IN VETERANS WITH LEG AMPUTATIONS. NEW AWARD.$2,000,000
· FY2020 · Defense Health Agency
A PLACEBO-CONTROLLED AUGMENTATION TRIAL OF PRAZOSIN FOR COMBAT TRAUMA PTSD$1,776,722
· FY2008 · Department of the Army
PRAZOSIN AUGEMENTATION OF OUTPATIENT TREATMENT OF ALCOHOL USE DISORDERS IN ACTIVE DUTY SOLDIERS WITH AND WITHOUT PTSD$1,400,000
· FY2012 · Department of Defense
SENSORY FEEDBACK FOR LOWER EXTREMITY PROSTHESES INCORPORATING TARGETED MUSCLE REINNERVATION (TMR)$1,327,480
· FY2015 · Department of the Army
THE ROLE OF MITOCHONDRIA IN ADT-INDUCED SARCOPENIA IN PROSTATE CANCER PATIENTS$1,069,689
· FY2018 · Defense Health Agency
STRESS AND PTSD MECHANISMS AS TARGETS FOR PHARMACOTHERAPY OF ALCOHOL ABUSE, ADDICTION AND RELAPSE$1,002,099
· FY2013 · Department of Defense
NOVEL LOWER-LIMB PROSTHESES: COMPARING ADHERENCE, PERSPIRATION, AND RESIDUAL LIMB SKIN HEALTH IN A HOT, HUMID ENVIRONMENT AND DURING ACTIVITIES OF DA$996,377
· FY2018 · Defense Health Agency
EFFECT OF PRAZOSIN AND NALTREXONE ON SCRIPTS INDUCED ALCOHOL CRAVING IN VETERANS WITH ALCOHOL USE DISORDERS WITH AND WITHOUT CO-OCCURRING PTSD$802,000
· FY2014 · Department of the Army
MEDICAL ADRENALECTOMY TO ABROGATE LIGAND PRODUCTION IN CASTRATION-RESISTANT PROSTATE CANCER$789,731
· FY2019 · Defense Health Agency
EFFICACY OF VIRTUAL WARRIOR RENEW THERAPY FOR VETERANS WHO EXPERIENCED MILITARY SEXUAL TRAUMA$749,967
· FY2022 · Defense Health Agency
GLIMPSE-PD: GLYMPHATICS IMAGING TO PROBE SLEEP IN PARKINSON'S DISEASE$674,746
· FY2024 · Defense Health Agency
PERSPIRATION THRESHOLDS AND SECURE SUSPENSION FOR LOWER LIMB AMPUTEES IN DEMANDING ENVIRONMENTS$673,299
· FY2014 · Department of the Army
BLAST CONCUSSION MTBI, HYPOPITUITARISM, AND PSYCHOLOGICAL HEALTH IN OIF/OEF VETERANS$356,127
· FY2011 · Department of Defense
OPTIMIZING PROSTHETIC PRESCRIPTION TO MITIGATE THE EFFECTS OF PERSPIRATION$349,737
· FY2021 · Defense Health Agency
REFUND CHECK IN THE AMOUNT OF $10.60$315,077
· FY2011 · Department of Defense
ORAL GUCY2C LIGAND BLOCKS COLORECTAL TUMOR PROGRESSION IN PATIENT$246,241
· FY2018 · Defense Health Agency